Rare Disease Advocates Lobby US Congress For FDA Center of Excellence

Number one ask is for congressional pressure to centralize rare disease expertise at the agency, but advocates also are preparing legislation that would mandate the new center.

FDAEntrance_1200x675
Rare disease advocates also want increased funding for the FDA Office of Orphan Products Development's clinical trial and natural history grant programs. • Source: File photo

Rare disease advocates want Congress to push the US Food and Drug Administration to create a Rare Disease Center of Excellence but have not ruled out forcing the reorganization, if necessary.

As part of Rare Disease Week activities, patients and other stakeholders lobbied lawmakers on 27 February to sign a letter...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership